These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36230236)

  • 1. Fibrinolysis in Dogs with Intracavitary Effusion: A Review.
    Zoia A; Drigo M; Caldin M; Simioni P; Piek CJ
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
    Zoia A; Drigo M; Piek CJ; Calcini H; Caldin M; Simioni P
    PLoS One; 2019; 14(11):e0225089. PubMed ID: 31725761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.
    Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
    PLoS One; 2018; 13(2):e0192371. PubMed ID: 29462172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.
    Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
    J Vet Intern Med; 2017 Jan; 31(1):43-50. PubMed ID: 27862300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ascites and primary hyperfibrinolysis: A cohort study in 210 dogs.
    Zoia A; Drigo M; Simioni P; Caldin M; Piek CJ
    Vet J; 2017 May; 223():12-20. PubMed ID: 28671065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic regulation and pathologic disorders of fibrinolysis.
    Francis CW; Marder VJ
    Hum Pathol; 1987 Mar; 18(3):263-74. PubMed ID: 3546075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.
    Thaler J; Lisman T; Quehenberger P; Hell L; Schwabl P; Scheiner B; Bucsics T; Nieuwland R; Ay C; Trauner M; Pabinger I; Reiberger T; Mandorfer M
    Thromb Haemost; 2022 Mar; 122(3):353-362. PubMed ID: 34020489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinolysis and Hypofibrinogenemia Diagnosed With Rotational Thromboelastometry in Dogs Naturally Infected With Angiostrongylus vasorum.
    Sigrist NE; Hofer-Inteeworn N; Jud Schefer R; Kuemmerle-Fraune C; Schnyder M; Kutter APN
    J Vet Intern Med; 2017 Jul; 31(4):1091-1099. PubMed ID: 28480552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment.
    Pitkänen HH; Kärki M; Niinikoski H; Tanner L; Näntö-Salonen K; Pikta M; Kopatz WF; Zuurveld M; Meijers JCM; Brinkman HJM; Lassila R
    Haemophilia; 2018 Sep; 24(5):e312-e321. PubMed ID: 30070418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of hyperfibrinolysis in dogs and cats demonstrated by rotational thromboelastometry (ROTEM).
    Sigrist NE; Schefer RJJ; Kutter APN
    Vet J; 2018 Dec; 242():67-73. PubMed ID: 30503547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hemostatic and fibrinolytic markers in dogs with ascites attributable to right-sided congestive heart failure.
    Zoia A; Augusto M; Drigo M; Caldin M
    J Am Vet Med Assoc; 2012 Nov; 241(10):1336-43. PubMed ID: 23113526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
    Moresco RN; Vargas LC; Voegeli CF; Santos RC
    J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of Fibrinogen and Fibrinolysis.
    May JE; Wolberg AS; Lim MY
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Severity of Fibrinolysis Based on Rotational Thromboelastometry and Conventional Fibrinolysis Markers.
    Saito T; Hayakawa M; Honma Y; Mizugaki A; Yoshida T; Katabami K; Wada T; Maekawa K
    Clin Appl Thromb Hemost; 2020; 26():1076029620933003. PubMed ID: 32571089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs.
    Stokol T
    Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1419-35. PubMed ID: 14664206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
    Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
    J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.